Genix PharmaceuticalsGENPF Quick Ratio is 0.02 as of Jan. 2026, which is 91% below its 10-year median of 0.22. The stock has 3 warning signs investors should review. Among 994 Drug Manufacturers companies, Genix Pharmaceuticals ranks worse than 99.3% on this metric.
Genix Pharmaceuticals has a quick ratio of 0.02. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Genix Pharmaceuticals's Quick Ratio or its related term are showing as below:
GENPF'
s Quick Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.22 Max: 3.25
Current: 0.02
During the past 13 years, Genix Pharmaceuticals's highest Quick Ratio was 3.25. The lowest was 0.01. And the median was 0.22.
GENPF's Quick Ratio is ranked worse than 99.3% of 994
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs GENPF: 0.02
Genix Pharmaceuticals (OTCPK:GENPF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Genix Pharmaceuticals Quick Ratio Related Terms
Genix Pharmaceuticals Quick Ratio Historical Data
* Premium members only.
The historical data trend for Genix Pharmaceuticals's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genix Pharmaceuticals Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Genix Pharmaceuticals's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Genix Pharmaceuticals's Quick Ratio for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genix Pharmaceuticals (GENPF) has a Quick Ratio of 0.02 as of Jan. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Genix Pharmaceuticals and its competitors. This is 91% below median its historical median of 0.22. Over the past decade, Genix Pharmaceuticals' Quick Ratio has ranged from 0.01 to 3.25. According to the industry distribution chart, Genix Pharmaceuticals ranks #987 out of 994 companies in the Drug Manufacturers industry, placing it in the top 99.3%.
Is Genix Pharmaceuticals' Quick Ratio too high?
Genix Pharmaceuticals' current Quick Ratio of 0.02 is 91% below median its 10-year median of 0.22. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 3.25. The Drug Manufacturers industry median Quick Ratio is 1.45. Genix Pharmaceuticals' value of 0.02 is 98.6% below this industry median. Based on the distribution chart, Genix Pharmaceuticals ranks #987 out of 994 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Genix Pharmaceuticals' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Genix Pharmaceuticals ranks #987 out of 994 companies for Quick Ratio. This places Genix Pharmaceuticals in the lower half of its industry. The industry median Quick Ratio is 1.45. Genix Pharmaceuticals' value of 0.02 is 98.6% below this benchmark. Historically, Genix Pharmaceuticals' own Quick Ratio has ranged from 0.01 to 3.25 over the past decade. While the company's 10-year median is 0.22 vs. the industry median of 1.45, Genix Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genix Pharmaceuticals's current Quick Ratio of 0.02 is 98.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Genix Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genix Pharmaceuticals's current Quick Ratio is 0.02, which is 91% below median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Quick Ratio of 0.02. The current Quick Ratio is 0.02, which is 91% below median its 10-year median of 0.22 and 98.6% below the Drug Manufacturers industry median of 1.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Quick Ratio is 0.02 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GENPF has been successfully added to your 